Rebirth 90: I opened a hospital in Shencheng

Chapter 423 Ye Wanqiu Holds a New Drug Launch Conference!
Nie Chen's steel-structure integrated Xinde pharmaceutical factory on Hongling Road in Shencheng has an assembly line for the production of this new drug.

This new drug is significantly better than the generic drug of Asan and even the original drug from the United States.

Even the expensive and advanced American original drugs can at most prolong the life of patients with advanced cancer by one to three years, and they have to suffer various side effects during the period.

Nie Chen's new drug is different. The drug is more targeted, has fewer side effects, and is more suitable for clinical practice.

and.

As long as it is produced on a large scale, the cost will be much lower than Ah San's generic drugs.

"Dr. Nie, it is very difficult to create a drug. It takes a lot of energy to do it. In the past few years, you have done a good job. Xinde Pharmaceutical has produced several internationally leading drugs. It is also the lowest in the world, and the contribution you and the pharmaceutical company have made to the common people is obvious to all!"

"Many things in the public opinion are blind. Many people don't know how many sacrifices Brother Chen and Xinde Pharmaceutical have made. They just blame you blindly. Brother Chen, don't take it to heart!"

Zhang Jingying comforted her.

She had seen how Nie Chen frantically researched new drugs day and night, and she also knew that these newly researched drugs were actually priceless.

If Nie Chen and Xinde Pharmaceutical engage in a monopoly to increase sales, the current size of the pharmaceutical factory may increase by more than ten times.

"Doctor Nie, you have done well enough, there is no need to be harsh on yourself!"

"The current Xinde Pharmaceutical and your contribution to this society are big enough!"

Professor Yang also persuaded.

"Doctor Nie, you don't need to pay attention to those ignorant netizens. They don't know how difficult it is to research a new drug!"

"Not to mention anything else, let's take Huixin Pharmaceutical as an example. It took more than 20 years for a drug with uncontrollable side effects. After the efforts of my parents, Uncle Wang Qiang, Wang Siyang and countless other people, I have the qualification to go on the market!"

Lin Ronghua also persuaded him.

He felt very uncomfortable when he mentioned the launch of Huixin Pharmaceutical's thrombolytic agent.

Until now, he still thinks there is something wrong with this drug.

If Wang Siyang and his laboratory can't solve the problem of the drug, they don't know how much harm it will bring to the patients and society when it breaks out completely.

I don't know if Huixin Pharmaceutical can bear the huge social responsibility.

"I hope the medicine developed by my parents is not too wrong!" Lin Ronghua said with a long breath.

"Don't worry, I won't care too much about what other people say!"

"And I didn't say that Xinde Pharmaceutical can produce cancer-targeted drugs!"

"We can produce better and more effective drugs, and we can completely circumvent the patented technologies of the American pharmaceutical company!"

"The new branch of the pharmaceutical factory has the equipment to produce this drug, and it will be put into production in about half a month, and then the first clinical trial will be carried out!"

Nie Chen said confidently.

Almost all the medical staff are concerned about Yang Zhongjun's purchasing agent case, and so is Nie Chen.

It was Zhou De and Chen Jimmy who defended Yang Zhongjun's innocence.

In order to defend Yang Zhongjun's innocence, they persuaded the procuratorate, the court, and well-known professors from various universities to come to the hearing together.

At the meeting, the two tried their best to defend Yang Zhongjun, and Jimmy Chen even confronted the judge.

Finally, the experts of the procuratorate were persuaded not to prosecute Yang Zhongjun.

Yang Zhongjun's purchasing behavior will no longer be held accountable.

At the same time, he also promised to all the experts at the hearing that he would not buy ibrutinib for anyone in the future, even if it was his own father.

If a suitable drug to treat his father is found, his father and a group of patients may only face the risk of death.

Yang Zhongjun was in a mixed mood when he came out of the hearing.

He knew that even if he continued to use Ah San's imitated ibrutinib, his father would only increase his lifespan by a few months, but his father's patients could live one, two or even three years longer.

Yang Zhongjun even regretted coming to this hearing, and regretted that he had made a promise not to help others purchase.

So what if he was sentenced to help prolong the lives of more people?

"Huaxia medical scientists and biochemists have been working hard to develop various new drugs, and we have never slacked off. We have never ignored any disease, nor ignored any patients. Huaxia medicine experts are capable of doing We will not lose to foreign experts, at least we are not willing to lose to them!"

"Xinde Pharmaceutical will produce a targeted drug similar to ibrutinib that can be used for the treatment of mid-to-late stages of cancer as soon as possible!"

"The Shencheng branch of the pharmaceutical factory has launched relevant equipment. It is expected that similar drugs will be produced and put into clinical trials within half a month. We guarantee that various production technologies and processes can completely avoid patents from Western countries and fully own our own knowledge. property!"

"The new targeted therapy drug produced by Xinde Pharmaceutical will avoid ibrutinib's method of attacking tumor blood vessels and adopt a new killing method, which will kill cancer cells more precisely!"

Just when the uproar of Yang Zhongjun's purchasing agent case ended.

Ye Wanqiu, chairman of Xinde Pharmaceutical, held a press conference in the China World Trade Center, and suddenly released a breaking news.

Xinde Pharmaceutical Shencheng Distribution is about to manufacture new targeted anticancer drugs.

As soon as the news came out, it immediately made the headlines of major media.

Newspapers outside of Shencheng reprinted it one after another.

The academician of the Chinese Academy of Sciences sent a congratulatory message immediately: "The medical laboratory of the Chinese Academy of Sciences is willing to cooperate with the Xinde Pharmaceutical Laboratory to jointly develop new drugs, and all relevant intellectual property rights belong to Xinde Pharmaceutical!"

The People's Daily published an editorial, highly appraising Nie Chen and Xinde Pharmaceuticals, saying that relevant departments will closely cooperate with the clinical trials of new drugs, and strive to make this targeted therapy drug available on the market as soon as possible.

"Excellent, Xinde Pharmaceutical, did not expect the domestic targeted anti-cancer drugs to come out so soon!"

"Xinde Pharmaceutical is powerful and supports domestic products. As long as the new drug has an effect, even if the price is comparable to the generic product of Asan, we will make the domestic drug!"

"On behalf of the vast number of cancer patients, especially those in the middle and late stages, I would like to thank you, Dr. Nie Chen!"

The news of Xinde Pharmaceutical's new drug release spread quickly in public opinion.

The news quickly spread abroad.

When the leaders of several foreign companies capable of producing ibrutinib saw the news, their faces were full of unconfidence.

They all know the origin of the drug ibrutinib.

Rather than saying that this drug was developed by scientists, it is better to say that it is a gift from God.

A few years ago, a doctor in a medical school made a mistake in a biochemical test and produced a substance that had never been studied before. This substance is the predecessor of ibrutinib.

However, the student was not discouraged. Instead, he studied the substance carefully with his tutor. To their surprise, they found that this substance could and only kill some stubborn cancer cells.

They registered and sold the patents to several giants in the world's pharmaceutical industry, including Pfizer and Johnson & Johnson.

"The appearance of ibrutinib was originally a joke made by God and human beings. The patented technology is well preserved by us, which can make Asan Pharmaceutical Company realize that similar substances are already at the limit. How can Chinese people say that they can produce similar substances? medicines?"

"Although Xinde Pharmaceutical's affiliated drugs are quite powerful, and although I believe in Nie Chen's scientific research capabilities, I don't believe that he can produce ibrutinib-like substances!"

"I will never believe it!"

The president of Pfizer saw this news when he checked the international medical newspaper prepared by his secretary in his office.

(End of this chapter)